WHO declares interest in Sputnik V coronavirus vaccine

“The interest remains ... We are exchanging information.

Here you need to look not only at the results of clinical trials, but also at industrial practice and permits for use in emergency situations, "- quoted by TASS Simao.

According to her, you need to "have all the information."

Earlier, the WHO representative in Russia, Melita Vuinovich, said that the organization's employees and the Russian developers of the Sputnik V vaccine are in dialogue on the procedure for its assessment.